Clinical Trials Browser

Not yet recruiting × bemarituzumab × 90 days × Clear all

NCT07470840 2026-03-17

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell